Unlock instant, AI-driven research and patent intelligence for your innovation.

Skin-permeating carrier containing nucleic acid complex and use thereof

A technology of skin penetration and compound, which is applied in the field of skin penetration carrier containing nucleic acid complex and its application, which can solve the problems that the effectiveness and stability of drugs cannot be guaranteed.

Inactive Publication Date: 2020-12-25
SEASUNBIO MATERIALS
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite the growing development costs of the commercialization steps of these studies, the effectiveness and stability of the drug to be delivered cannot be guaranteed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Skin-permeating carrier containing nucleic acid complex and use thereof
  • Skin-permeating carrier containing nucleic acid complex and use thereof
  • Skin-permeating carrier containing nucleic acid complex and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0197] Example 1: Preparation of biologically active nucleic acid, carrier peptide nucleic acid and complex using them.

[0198] To confirm the skin penetration and skin maintenance effects of the nucleic acid complex of structural formula (1) according to the present invention, IFI16, a gene targeting psoriatic disease, was used as a target gene. IFI16 is a protein commonly expressed in the skin of patients with psoriasis and is considered an important target for the treatment of psoriasis (upregulation of interferon-inducible protein 16 leads to psoriasis by modulating chemokine production in keratinocytes Disease 6:25381).

[0199] To evaluate the skin penetration and skin retention of nucleic acid complexes, antisense peptide nucleic acid (PNA) and RNA were used as bioactive nucleic acids against IFI16.

[0200] The biologically active nucleic acids (antisense PNA and RNA) of the present invention have the sequences shown in SEQ ID NO: 1-9. The peptide nucleic acid-based...

Embodiment 2

[0207] Example 2: Analysis of Skin Penetration of Nucleic Acid Complexes Comprising Biologically Active Nucleic Acids and Carrier Peptide Nucleic Acids

[0208] In order to analyze the skin penetration of the complexes prepared in Example 1, a predetermined amount of each compound was applied to the back of nude mice, and then left for 1, 3 and 24 hours, and the tissue of the applied area was biopsied. The biopsied tissues were fixed in 4% formalin solution, kept for 1 day, sectioned into 20 μm sections using a microtome, and mounted on glass slides. The affixed tissue was observed under a fluorescence microscope to check whether the complex penetrated the skin.

[0209] The nucleic acid complexes used in this example are shown in Table 3 below.

[0210] [Table 3] Nucleic acid complexes used for analysis of skin penetration

[0211] name nucleic acid complex single siRNA SEQ ID NO:8 siRNA duplex SEQ ID NO: 8 and 10 Single PNA SEQ ID NO:1 ...

Embodiment 3

[0213] Example 3: Analysis of the skin penetration of a skin permeable carrier comprising a complex having the structure of formula (1) to which a low molecular weight substance is bound via a linker

[0214] In order to analyze the skin penetration of the skin permeable carrier in which the low-molecular-weight substance was bound to each complex via a linker compared with each complex prepared in Example 1, a predetermined amount of each complex was applied to the back of nude mice , followed by leaving it on for 0, 3 and 24 hours, biopsies were taken from the area of ​​application. Biopsies were fixed in 4% formalin, kept for 1 day, sectioned into 20 μm sections using a microtome, and mounted on glass slides. The affixed tissue was observed by fluorescence microscopy to examine the transdermal delivery of the skin-permeable vehicle, in which low molecular weight substances were bound to each nucleic acid complex.

[0215] The nucleic acid complexes used in this example are...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The present invention relates to: a skin-permeating carrier containing a novel-structured nucleic acid complex for enabling a bioactive nucleic acid to be introduced into a cell; and a composition comprising same, for diagnosing, preventing or treating a disease. More specifically, the present invention relates to: a skin-permeating carrier exhibiting skin permeability and skin retention, and containing a nucleic acid complex having a bioactive nucleic acid complementarily bound with a carrier peptide nucleic acid; and a composition comprising same, for diagnosing, preventing or treating a disease. According to the present invention, the skin-permeating carrier containing the nucleic acid complex having a structure represented by structural formula (1) has, simultaneously, in vivo efficacyand a skin permeation function for effectively delivering a drug having a large molecular weight. Especially, the carrier, according to the present invention, enables the bioactive nucleic acid or various compounds to pass through the epidermis and dermis of skin, and thus enables external treatment whereby the carrier is applied on the surface of skin.

Description

technical field [0001] The present invention relates to a skin-penetrating carrier containing a nucleic acid complex capable of introducing biologically active nucleic acids into cells and a composition for diagnosing, preventing or treating diseases comprising the skin-penetrating carrier, more specifically, to a skin-penetrating carrier comprising A skin-penetrating carrier in which a nucleic acid complex of a biologically active nucleic acid and a carrier peptide nucleic acid are complementary to each other and has skin-penetrating ability and skin-retaining ability, and a composition for diagnosing, preventing or treating a disease comprising the same. Background technique [0002] Unlike conventional drugs, nucleic acid drugs inhibit the expression of target-specific messenger RNA (mRNA), thus potentially addressing areas of research that cannot be treated with conventional drugs targeting proteins (Kole R. et al., Nature Rev. Drug Discov. 2012; 11; 125-140., Wilson C. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/64A61K47/54A61K9/00A61K31/7052A61K31/7088A61K31/713A61K45/06A61P3/00A61P9/10A61P17/00A61P17/02A61P17/06A61P27/02A61P35/00
CPCA61K47/64A61K47/549A61K45/06A61K31/7052A61K31/7088A61K31/713A61K9/0014A61P17/00A61P35/00A61P27/02A61P9/10A61P9/00A61P3/10A61P3/00A61P17/06A61P17/02C12Q1/6886C12Q1/6883A61K47/6455C12N15/87C12N15/111C12N2310/3519C12N2310/3181C12N2320/32A61K48/0041A61P35/04A61K48/00C12N15/113C12N15/1138C12N2310/11C12N2310/14C12N2310/3513
Inventor 金惠周柳之娟李同仁姜宥先朴希卿
Owner SEASUNBIO MATERIALS